 This was needed because of the concern that long term use of SERMs could lead to osteoporosis and heart disease.Jordan's research showed that post-menopausal women who took these drugs did not suffer from a lowering of bone density or an increase in blood cholesterol.Raloxifene is now used in the prevention of osteoporosis.